Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04985604
Title Tovorafenib (DAY101) Monotherapy or in Combination With Other Therapies for Patients With Melanoma and Other Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Day One Biopharmaceuticals, Inc.
Age Groups: adult | child | senior
Covered Countries USA | FRA | ESP | CAN | BEL | AUS

Additional content available in CKB BOOST